SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001437749-23-008637
Filing Date
2023-03-30
Accepted
2023-03-30 16:30:07
Documents
1
Group Members
DRUGCRAFTERS, LPDUGABOY INVESTMENT TRUSTHIGHLAND GLOBAL ALLOCATION FUNDJAMES D. DONDERONANCY MARIE DONDERONEXPOINT ADVISORS, L.P.NEXPOINT ASSET MANAGEMENT, L.P.NEXPOINT CLIMATE TECH FUNDNEXPOINT EVENT DRIVEN FUND

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D nreo20230330_sc13d.htm SC 13D 419271
  Complete submission text file 0001437749-23-008637.txt   421344
Mailing Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116
Business Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116 (617) 807-6600
Paratek Pharmaceuticals, Inc. (Subject) CIK: 0001178711 (see all company filings)

IRS No.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-81821 | Film No.: 23781091
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 CRESCENT COURT SUITE 700 DALLAS TX 75201
Business Address 300 CRESCENT COURT SUITE 700 DALLAS TX 75201 214-276-6300
NexPoint Real Estate Opportunities, LLC (Filed by) CIK: 0001957368 (see all company filings)

IRS No.: 461019134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D